← Open Payments lookup

KARINE KIRAKOSYAN: Open Payments

NPI 1427092071 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,804 in 85 payments from 17 companies in 2025. Trend: 2023 $1,522 · 2024 $1,648 · 2025 $1,804

Food & beverage: $1,804
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP16$455
ABBVIE INC.14$292
Sumitomo Pharma America, Inc.10$262
Amgen Inc.18$164
GlaxoSmithKline, LLC.7$147
PFIZER INC.3$79
Ardelyx, Inc.3$73
Boehringer Ingelheim Pharmaceuticals, Inc.2$56
Lundbeck LLC2$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42

Products named: BREZTRI, GEMTESA, QULIPTA, TRELEGY ELLIPTA, AIRSUPRA, JARDIANCE, OTEZLA, NURTEC ODT.

Industry payments across CA — which companies pay providers there.